Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from InnoCare Pharma Ltd. ( (HK:9969) ) is now available.
InnoCare Pharma Ltd. has announced a board meeting scheduled for March 27, 2025, to consider and approve the annual financial results for the year ending December 31, 2024. This meeting is significant as it will impact the company’s financial disclosures and could influence stakeholder perceptions and market positioning.
More about InnoCare Pharma Ltd.
InnoCare Pharma Ltd. is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative drugs. The company operates in the healthcare industry, with a primary focus on creating treatments for cancer and autoimmune diseases.
YTD Price Performance: 42.65%
Average Trading Volume: 7,893,520
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$13.14B
See more insights into 9969 stock on TipRanks’ Stock Analysis page.